Skip to main content

Table 1 Baseline data on study subjects

From: Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure

N 56
Sex (M/F) 46/10 (82.1%)
Age (y) 60.84
BMI (kg/m2) 25.07
Blood pressure(SBP/DBP) (mmHg) 138 (9.67)/78.6 (11.5)
Dulation (y) 15.47 (10.67)
Laboratory data
HbA1c (%) 6.87 (0.68)
FPG (mg/dl) 151.7 (47.5)
LDL-C (mg/dl) 109.7 (25.3)
HDL-C (mg/dl) 55.7(12.8)
Triglycerides (mg/dl) 150(83.0)
Creatinine (mg/dl) 0.80 (0.18)
Blood glucose lowering treatment
Insulin only 9
Insulin+OHA 6
OHA 31
Diet only 6
Dropped out 10
  1. F, female; M, male, BMI, Body-mass index; HbA1c, glycated hemoglobin; FPG, fasting plasma glucose; LDL-C, Low density lipoprotein-cholesterol; HDL-C, High density lipoprotein-cholesterol; OHA, oral hypoglycemic agent, *P<0.05. Data are expressed as means±s.d. or n and%.